Skip to content
Review

CRISPR-Cas-based detection of Mycobacterium tuberculosis: current advances and translational bottlenecks.

Aug 2026 · Protoplasma · 1 citation · 82 references
Medicine

TL;DR

It is highlighted that successful clinical translation of CRISPR-based TB diagnostics is determined more by real-world adaptability than by analytical performance alone, and the variability in assay design, analytical and clinical performance, and translational readiness across currently available systems is evaluated.

View source

Similar papers

Review Open access Aug 2026

Research Progress in Applications of the CRISPR-Cas12b System in Pathogen Nucleic Acid Detection

A comprehensive evaluation of current applications demonstrates the efficacy of CRISPR-Cas12b-based diagnostics across diverse pathogens, including viruses, bacteria, and parasites, with a specific focus on its integration with isothermal amplification techniques.

Jiang-Ying Li, Xue-Yong Zhang · 0 citations
Review

Harnessing the synergy of CRISPR-Cas12 with isothermal amplification for precise and rapid detection of tuberculosis: a systematic review

Evaluating the diagnostic performance of CRISPR-Cas12 systems integrated with isothermal amplification techniques for MTB detection demonstrates high diagnostic potential for TB detection, offering excellent sensitivity and specificity, rapid turnaround time, and suitability for point-of-care testing.

B. Bintoro, I. A. Saharani · 1 citation
Review Open access Aug 2026

LAMP-CRISPR Integrated Platforms for Rapid Detection of Microbial Pathogens: Principles, Applied Strategies, and the Road to Field Translation.

This review provides a structured overview of current LAMP-CRISPR platforms and highlights key technological considerations for translating rapid microbial pathogen detection from laboratory research to real-world applications.

Yi Xu, Xiao-Jiao He, Tian-Le Xu · 0 citations
Open access Sep 2026

An FTA card-based CRISPR/Cas12a platform with isothermal amplification for portable tuberculosis diagnosis

Mycobacterium tuberculosis remains a major global public health threat, imposing significant socioeconomic burdens. Current molecular diagnostics rely heavily on nucleic acid extraction and specialized equipment, which limits their use in resource-limited settings. We developed a rapid, sensitive platform suitable for...

Jia-Yin Xing, Xiang-Xiang Zhao, Gao-Jie Wang et al. · 0 citations
Review Oct 2026

Molecular Programming of CRISPR Diagnostics: From Target Recognition to Field Deployment.

An integrated framework that connects five coupled design layers with five levels of translational evidence shifts the evaluation of CRISPR diagnostics from isolated analytical performance toward evidence-based workflow co-design.

Heng-Yu Wang, Mei-You Chen, Qiu-Run He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.